Clinical and Translational Oncology

, Volume 18, Issue 8, pp 825–830 | Cite as

Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer

  • M. MartínEmail author
  • A. Hinojar
  • L. Cerezo
  • J. García
  • M. Lopez
  • J. Prada
  • A. Marín
  • C. Gamallo
Research Article



Aldehyde dehydrogenase isoform 1 (ALDH1) has been shown to be a marker of cancer stem cells (CSCs). These stem cells may be responsible for tumour perpetuation as well as local and distant invasion. Several studies have shown that CSCs are more chemoradiotherapy (CRT)-resistant and may be responsible for tumour recurrence. Other studies, in contrast, have found ALDH1 expression to be indicative of a better prognosis.


We retrospectively evaluated 84 patients diagnosed and treated for laryngeal cancer between 2006 and 2011. All patients underwent curative-intent radiotherapy or CRT at our institution. 57 of the 84 tumour samples contained sufficient material for ALDH1 assessment.


ALDH1 expression was detected in 17.5 % (10/57) of the tissue samples. None of the tumours from stage I patients tested positive for ALDH1. The relapse rate in ALDH1 + patients was 10 versus 51.2 % for ALDH1−. No differences in overall survival were observed between the groups; however, disease-free survival was 90 % for the ALDH1 + group versus 48.9 % for ALDH1− patients (p = 0.034).


The patients in this study with ALDH1 + tumours had better outcomes than their counterparts with ALDH1− tumours. This finding suggests that not all CSCs are resistant to conventional cancer treatments. It may also imply that new methods of correctly identifying these cells are needed.


Aldehyde dehydrogenase Cancer stem cells Larynx carcinoma Radiotherapy 



This work was supported by Grant from the Fundación Mutua Madrileña (no. MUT02.2011). We wish to thank Mr Bradley Londres for his assistance in editing and improving the manuscript.

Conflict of interest

The authors have declared that not conflict of interest exists.

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

For this type of study, formal consent is not required.


  1. 1.
    Reya T, Msorrison S, Clarke M, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105–11.CrossRefPubMedGoogle Scholar
  2. 2.
    Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66(19):9339–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, Prince ME, et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res. 2010;70(23):9969–78.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Marynka-Kalmani K, Treves S, Yafee M, Rachima H, Gafni Y, Cohen MA, et al. The lamina propria of adult human oral mucosa harbors a novel stem cell population. Stem Cells. 2010;28(5):984–95.PubMedGoogle Scholar
  5. 5.
    Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett. 2010;289(2):151–60.CrossRefPubMedGoogle Scholar
  6. 6.
    Chen H, Zhou L, Dou T, Wan G, Tang H, Tian J. BMI1’S maintenance of the proliferative capacity of laryngeal cancer stem cells. Head Neck. 2011;33(8):1115–25.CrossRefPubMedGoogle Scholar
  7. 7.
    de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, et al. CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res. 2010;16(21):5329–38.CrossRefPubMedGoogle Scholar
  8. 8.
    Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 2009;385(3):307–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Croker AK, Allan AL. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44(+) human breast cancer cells. Breast Cancer Res Treat. 2012;133(1):75–87.CrossRefPubMedGoogle Scholar
  10. 10.
    Greco N, Schott T, Mu X, Rothenberg A, Voigt C, McGough RL III, et al. ALDH activity correlates with metastatic potential in primary sarcomas of bone. J Cancer Ther. 2014;5(4):331–8.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, Szczepanski MJ, et al. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8 T cells. Clin Cancer Res. 2011;17(19):6174–84.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Pors K, Moreb JS. Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development? Drug Discov Today. 2014;19(12):1953–63.CrossRefPubMedGoogle Scholar
  13. 13.
    Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck. 2010;32(9):1195–201.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM, et al. Evidence for epithelial–mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS ONE. 2011;6(1):e16466.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Koukourakis MI, Giatromanolaki A, Tsakmaki V, Danielidis V, Sivridis E. Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer. Br J Cancer. 2012;106(5):846–53.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Al-Assar O, Muschel RJ, Mantoni TS, McKenna WG, Brunner TB. Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers. Int J Radiat Oncol Biol Phys. 2009;75(4):1216–25.CrossRefPubMedGoogle Scholar
  17. 17.
    Zielske SP, Spalding AC, Wicha MS, Lawrence TS. Ablation of breast cancer stem cells with radiation. Transl Oncol. 2011;4(4):227–33.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Chen YW, Chen KH, Huang PI, Chen YC, Chiou GY, Lo WL, et al. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44(+)ALDH1(+) cells. Mol Cancer Ther. 2010;9(11):2879–92.CrossRefPubMedGoogle Scholar
  19. 19.
    Qian X, Wagner S, Ma C, Coordes A, Gekeler J, Klussmann JP, et al. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 2014;140(7):1151–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Xu J, Muller S, Nannapaneni S, Pan L, Wang Y, Peng X, et al. Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer. Eur J Cancer. 2012;48(11):1682–91.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Zhou C, Sun B. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis. Oral Oncol. 2014;50(12):1144–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Lopez-Gonzalez A, Salas C, Provencio M, Cordoba M, Gamallo C. Aldehyde dehydrogenases in early stage lung cancer: nuclear expression. Clin Transl Oncol. 2014;16(10):931–4.CrossRefPubMedGoogle Scholar
  23. 23.
    Michifuri Y, Hirohashi Y, Torigoe T, Miyazaki A, Kobayashi J, Sasaki T, et al. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol Int. 2012;62(10):684–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Qian X, Wagner S, Ma C, Klussmann JP, Hummel M, Kaufmann AM, et al. ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status. Oncol Rep. 2013;29(5):1777–84.PubMedGoogle Scholar

Copyright information

© Federación de Sociedades Españolas de Oncología (FESEO) 2015

Authors and Affiliations

  • M. Martín
    • 1
    Email author
  • A. Hinojar
    • 2
  • L. Cerezo
    • 1
  • J. García
    • 3
  • M. Lopez
    • 1
  • J. Prada
    • 2
  • A. Marín
    • 1
  • C. Gamallo
    • 4
  1. 1.Department of Radiation OncologyInstituto de Investigación Hospital de La PrincesaMadridSpain
  2. 2.Department of OtorhinolaryngologyInstituto de Investigación Hospital de La PrincesaMadridSpain
  3. 3.Department of OtorhinolaryngologyHospital Universitario Infanta SofíaMadridSpain
  4. 4.Department of PathologyInstituto de Investigación Hospital de La PrincesaMadridSpain

Personalised recommendations